This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • PET-MR-PSA Prostate Cancer Recidive Study
Clinical trial

PET-MR-PSA Prostate Cancer Recidive Study

Read time: 1 mins
Last updated:1st Sep 2015

Simultaneous PET/MRI has the potential to improve the detection accuracy in recurrent prostate cancer, since it combines the excellent soft-tissue contrast of MRI with the high molecular sensitivity of PET in a single imaging session. The aim of this study is to evaluate the sensitivity and specificity of simultaneous 18F-Fluciclovine PET/MRI for detection of recurrent prostate cancer.


Study Type: Observational

Study Design: Observational Model: Case-Only

Time Perspective: Prospective

Official Title: 18F-Fluciclovine PET/MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

Estimated Enrollment: 80

Study Start Date: September 2015

Estimated Study Completion Date: December 2027

Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)

Category Value
Study start date 2015-09-01

View full details